Results 131 to 140 of about 2,521,110 (208)

Novel Pharmacotherapies for Treatment-Resistant Depression: Lysergic Acid Diethylamide (LSD)

Treatment Resistant Depression has become extremely prevalent with 30% of depression cases being unresolvable. Psychedelics specifically Lysergic Acid Diethylamide has been a newfound unconventional approach that has demonstrated significant benefits for
Eliana Cohen
core   +1 more source

Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study. [PDF]

Neuropsychopharmacology
Calder AE, Diehl VJ, Lietz MP, Yousefi P, Friedli N, Coviello F, Rouaud A, Beichmann K, Eckert A, Hasler G.   +9 more
europepmc   +1 more source

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants. [PDF]

Clin Pharmacol Ther, 2021
Holze F, Liechti ME, Hutten NRPW, Mason NL, Dolder PC, Theunissen EL, Duthaler U, Feilding A, Ramaekers JG, Kuypers KPC.   +9 more
europepmc   +1 more source

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment. [PDF]

Cell Rep Med
Avram M, Menegaux A, Müller F, Zaczek H, Korda A, Rogg H, Becker AM, Ley L, Liechti ME, Borgwardt S.   +9 more
europepmc   +1 more source

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice. [PDF]

J Psychopharmacol, 2022
Elsilä LV, Harkki J, Enberg E, Martti A, Linden AM, Korpi ER.   +5 more
europepmc   +1 more source

Lysergic acid diethylamide and chromosome breakage

Hereditas, 2009
S, Sturelid, B A, Kihlman
openaire   +2 more sources

Effect of liner properties on the analysis of lysergic acid diethylamide (LSD) analogs. [PDF]

J Forensic Sci
Shuda SA.
europepmc   +1 more source

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. [PDF]

Neuropsychopharmacology, 2022
Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P, Kuehne SS, Roder MA, Duthaler U, Kolaczynska KE, Varghese N, Eckert A, Liechti ME.   +12 more
europepmc   +1 more source

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers. [PDF]

Br J Pain
Cavarra M, Hutten NRPW, Schepers J, Mason NL, Theunissen EL, Liechti ME, Kuypers KPC, Bonnelle V, Feilding A, Ramaekers JG.   +9 more
europepmc   +1 more source

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). [PDF]

Drug Test Anal, 2022
Brandt SD, Kavanagh PV, Westphal F, Pulver B, Morton K, Stratford A, Dowling G, Halberstadt AL.   +7 more
europepmc   +1 more source